£7 million for UK-Israel joint research
The Britain Israel Research Academic Exchange (BIRAX) has funded over £7 million in 15 bilateral research programs including stem cell treatments for multiple sclerosis and Parkinson's disease and therapies for Type 1 diabetes.
Eye-Control is life-changing technology
Latest video about Israel’s Eye-Control, a compact and affordable invention that gives a voice to locked-in patients who were unable to communicate, due to diseases such as ALS. With Eye-Control individuals use their eyes to spell out words and statements, proving that the eyes really are the window into the soul.
Alzheimer’s disease can be seen in the eyes
Researchers at Israel’s Sheba Medical Center have discovered a connection between mild cognitive impairment and the response of that person’s eye pupil to red and blue light. More tests will check if loss of retina function is an early warning of Alzheimer’s disease.
Good results in acne dual-treatment trials
Israeli biotech Sol-Gel has announced positive interim results in its Phase II clinical trial for its “Twin” treatment for acne. “Twin” combines two known acne treatments with a unique method of molecular wrapping that makes it easier to penetrate the skin.
Israeli thorn bush treats diabetes
Dr. Tovit Rosenzweig of Ariel University has discovered that the Israeli plant Sarcopoterium Spinosum (sira kotzanit / thorny burnet) can balance blood sugar levels. Dr. Rosenzweig is developing a treatment from the plant that could benefit more than 200 million diabetes sufferers worldwide.
New treatment for Tourette Syndrome
Israel’s Therapix Biosciences is conducting a proof-of-concept Phase II clinical study with the Hannover Medical School, of its lead compound THX-TS01 for 20 patients suffering from Tourette Syndrome.
Universal Flu vaccine’s positive trial results confirmed
Final results of BiondVax’s Phase 2b trials of its Universal Flu vaccine confirmed preliminary results reported here previously. Both endpoints were met. Immune response to the vaccine was statistically significant. BiondVax can now proceed to Phase 3 final trials.
Hypoparathyroidism biotech heads for NASDAQ
I reported previously on Israel’s Entera Bio which is testing treatments for disorders in the parathyroid gland, and osteoporosis. Entera Bio has now filed for floating the biotech on NASDAQ to fund Phase II/III trials of its treatment for hypoparathyroidism.
Looking good
A research team from Israel’s Bar-Ilan University has developed “Prophecy” - a first-ever formula that lets hyaluronic acid penetrate the deeper skin layers, to smooth out wrinkles using a cream and without injection. Hyaluronic acid absorbs water to smooth the skin and has antioxidant properties to slow the aging process.
Enabling the mute to speak
Israeli charity Ezer Mizion recently hosted a major conference on Alternative and Augmentative Communication (AAC). The aim of the conference was to share the cutting-edge knowledge that Ezer Mizion has been advancing. Those on Facebook please watch the video of the conference’s opening.